The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids.
Cannabinoid 2 receptor (CB2R) agonists attenuate inflammatory pain but the precise mechanism implicated in these effects is not completely elucidated. We investigated if the peripheral nitric oxide-cGMP-protein kinase G (PKG)-ATP-sensitive K(+) (KATP) channels signaling pathway triggered by the neur...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3198780?pdf=render |
id |
doaj-20d8dc1e986d48c8a411b2c799cce3dd |
---|---|
record_format |
Article |
spelling |
doaj-20d8dc1e986d48c8a411b2c799cce3dd2020-11-25T01:31:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2668810.1371/journal.pone.0026688The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids.Roger NegreteArnau HerveraSergi LeánezJesús M Martín-CamposOlga PolCannabinoid 2 receptor (CB2R) agonists attenuate inflammatory pain but the precise mechanism implicated in these effects is not completely elucidated. We investigated if the peripheral nitric oxide-cGMP-protein kinase G (PKG)-ATP-sensitive K(+) (KATP) channels signaling pathway triggered by the neuronal nitric oxide synthase (NOS1) and modulated by opioids, participates in the local antinociceptive effects produced by a CB2R agonist (JWH-015) during chronic inflammatory pain.In wild type (WT) and NOS1 knockout (NOS1-KO) mice, at 10 days after the subplantar administration of complete Freund's adjuvant (CFA), we evaluated the antiallodynic (von Frey filaments) and antihyperalgesic (plantar test) effects produced by the subplantar administration of JWH-015 and the reversion of their effects by the local co-administration with CB2R (AM630), peripheral opioid receptor (naloxone methiodide, NX-ME) or CB1R (AM251) antagonists. Expression of CB2R and NOS1 as well as the antinociceptive effects produced by a high dose of JWH-015 combined with different doses of selective L-guanylate cyclase (ODQ) or PKG (Rp-8-pCPT-cGMPs) inhibitors or a KATP channel blocker (glibenclamide), were also assessed. Results show that the local administration of JWH-015 dose-dependently inhibited the mechanical and thermal hypersensitivity induced by CFA which effects were completely reversed by the local co-administration of AM630 or NX-ME, but not AM251. Inflammatory pain increased the paw expression of CB2R and the dorsal root ganglia transcription of NOS1. Moreover, the antinociceptive effects of JWH-015 were absent in NOS1-KO mice and diminished by their co-administration with ODQ, Rp-8-pCPT-cGMPs or glibenclamide.These data indicate that the peripheral antinociceptive effects of JWH-015 during chronic inflammatory pain are mainly produced by the local activation of the nitric oxide-cGMP-PKG-KATP signaling pathway, triggered by NOS1 and mediated by endogenous opioids. These findings suggest that the activation of this pathway might be an interesting therapeutic target for the treatment of chronic inflammatory pain with cannabinoids.http://europepmc.org/articles/PMC3198780?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Roger Negrete Arnau Hervera Sergi Leánez Jesús M Martín-Campos Olga Pol |
spellingShingle |
Roger Negrete Arnau Hervera Sergi Leánez Jesús M Martín-Campos Olga Pol The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. PLoS ONE |
author_facet |
Roger Negrete Arnau Hervera Sergi Leánez Jesús M Martín-Campos Olga Pol |
author_sort |
Roger Negrete |
title |
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. |
title_short |
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. |
title_full |
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. |
title_fullStr |
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. |
title_full_unstemmed |
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. |
title_sort |
antinociceptive effects of jwh-015 in chronic inflammatory pain are produced by nitric oxide-cgmp-pkg-katp pathway activation mediated by opioids. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2011-01-01 |
description |
Cannabinoid 2 receptor (CB2R) agonists attenuate inflammatory pain but the precise mechanism implicated in these effects is not completely elucidated. We investigated if the peripheral nitric oxide-cGMP-protein kinase G (PKG)-ATP-sensitive K(+) (KATP) channels signaling pathway triggered by the neuronal nitric oxide synthase (NOS1) and modulated by opioids, participates in the local antinociceptive effects produced by a CB2R agonist (JWH-015) during chronic inflammatory pain.In wild type (WT) and NOS1 knockout (NOS1-KO) mice, at 10 days after the subplantar administration of complete Freund's adjuvant (CFA), we evaluated the antiallodynic (von Frey filaments) and antihyperalgesic (plantar test) effects produced by the subplantar administration of JWH-015 and the reversion of their effects by the local co-administration with CB2R (AM630), peripheral opioid receptor (naloxone methiodide, NX-ME) or CB1R (AM251) antagonists. Expression of CB2R and NOS1 as well as the antinociceptive effects produced by a high dose of JWH-015 combined with different doses of selective L-guanylate cyclase (ODQ) or PKG (Rp-8-pCPT-cGMPs) inhibitors or a KATP channel blocker (glibenclamide), were also assessed. Results show that the local administration of JWH-015 dose-dependently inhibited the mechanical and thermal hypersensitivity induced by CFA which effects were completely reversed by the local co-administration of AM630 or NX-ME, but not AM251. Inflammatory pain increased the paw expression of CB2R and the dorsal root ganglia transcription of NOS1. Moreover, the antinociceptive effects of JWH-015 were absent in NOS1-KO mice and diminished by their co-administration with ODQ, Rp-8-pCPT-cGMPs or glibenclamide.These data indicate that the peripheral antinociceptive effects of JWH-015 during chronic inflammatory pain are mainly produced by the local activation of the nitric oxide-cGMP-PKG-KATP signaling pathway, triggered by NOS1 and mediated by endogenous opioids. These findings suggest that the activation of this pathway might be an interesting therapeutic target for the treatment of chronic inflammatory pain with cannabinoids. |
url |
http://europepmc.org/articles/PMC3198780?pdf=render |
work_keys_str_mv |
AT rogernegrete theantinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT arnauhervera theantinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT sergileanez theantinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT jesusmmartincampos theantinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT olgapol theantinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT rogernegrete antinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT arnauhervera antinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT sergileanez antinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT jesusmmartincampos antinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids AT olgapol antinociceptiveeffectsofjwh015inchronicinflammatorypainareproducedbynitricoxidecgmppkgkatppathwayactivationmediatedbyopioids |
_version_ |
1725085512306262016 |